[Ip-health] Bloomberg: Tillis, Coons to Hold New Huddles on Patent Eligibility Proposal
james.love at keionline.org
Mon Aug 19 13:42:59 PDT 2019
We will ask Tills and Coons for a list of who is attending these meetings.
News: Tillis, Coons to Hold New Huddles on Patent Eligibility Proposal
Aug. 19, 2019
Hill meetings scheduled Aug. 20, 21
Lawmakers seek feedback on revised draft
Sens. Thom Tillis and Chris Coons have summoned stakeholders to a fresh
round of closed-door meetings on a revised proposal to rewrite patent
Tillis (R-N.C.) and Coons (D-Del.) have scheduled two meetings, for Aug. 20
and 21, according to sources familiar with the effort.
The draft proposal could undo several U.S. Supreme Court decisions on what
inventions deserve patent protection. The rulings have left the law poorly
defined, and made it harder for companies to win patents and raise venture
capital, attorneys and some trade groups say.
Participants will be given 30 minutes to review the new draft, but must
leave the document and any notes behind at the end of the meeting,
according to an invitation obtained by Bloomberg Law.
The participants will discuss revisions made after three patent eligibility
hearings held in June by Tillis, the chairman of the Senate Judiciary
Committee’s intellectual property subcommittee, and Coons, the
subcommittee’s ranking member, the email said. The pair last floated a
proposal in May.
. . .
Representatives from trade groups, technology and pharmaceutical companies
or legal associations will likely attend the meetings, the sources said.
Alphabet Inc.'s Google, Qualcomm Inc., Genetech Inc., pharmaceutical
industry group PhRMA, and the Biotechnology Innovation Organization, among
others, were invited to earlier meetings.
. . .
. . .
To contact the reporter on this story: Malathi Nayak in Washington at
mnayak at bloomberglaw.com
To contact the editor responsible for this story: Keith Perine at
kperine at bloomberglaw.com
James Love. Knowledge Ecology International
U.S. Mobile +1.202.361.3040
U.S. office phone +1.202.332.2670
More information about the Ip-health